On the Role of Baseline Measurements for Crossover Designs under the Self and Mixed Carryover Effects Model

It is well known that optimal designs are strongly model dependent. In this article, we apply the Lagrange multiplier approach to the optimal design problem, using a recently proposed model for carryover effects. Generally, crossover designs are not recommended when carryover effects are present and when the primary goal is to obtain an unbiased estimate of the treatment effect. In some cases, baseline measurements are believed to improve design efficiency. This article examines the impact of baselines on optimal designs using two different assumptions about carryover effects during baseline periods and employing a nontraditional crossover design model. As anticipated, baseline observations improve design efficiency considerably for two-period designs, which use the data in the first period only to obtain unbiased estimates of treatment effects, while the improvement is rather modest for three- or four-period designs. Further, we find little additional benefits for measuring baselines at each treatment period as compared to measuring baselines only in the first period. Although our study of baselines did not change the results on optimal designs that are reported in the literature, the problem of strong model dependency problem is generally recognized. The advantage of using multiperiod designs is rather evident, as we found that extending two-period designs to three- or four-period designs significantly reduced variability in estimating the direct treatment effect contrast.

[1]  R. Mukerjee,et al.  Optimal repeated measurements designs under interaction , 1987 .

[2]  A. S. Hedayat,et al.  Optimal and Efficient Crossover Designs When Subject Effects Are Random , 2006 .

[3]  S. Manuck,et al.  Behaviorally Induced Heart Rate Reactivity and Atherosclerosis in Cynomolgus Monkeys , 1983, Psychosomatic medicine.

[4]  S. Wallenstein,et al.  The analysis of the two-period repeated measurements crossover design with application to clinical trials. , 1977, Biometrics.

[5]  J. Kunert Optimality of Balanced Uniform Repeated Measurements Designs , 1984 .

[6]  C. Sharpley Effects of brief rest periods upon heart rate in multiple baseline studies of heart rate reactivity , 1993, Biofeedback and self-regulation.

[7]  S. Manuck,et al.  Acute psychophysiologic reactivity and risk of cardiovascular disease: a review and methodologic critique. , 1984, Psychological bulletin.

[8]  Keumhee C. Carriere,et al.  Multiple-objective response-adaptive repeated measurement designs for clinical trials , 2009 .

[9]  Morris Meisner,et al.  A Variational Approach to Optimal Two-Treatment Crossover Designs: Application to Carryover-Effect Models , 1985 .

[10]  B. W. Brown The crossover experiment for clinical trials. , 1980, Biometrics.

[11]  A. Hedayat,et al.  Repeated measurements designs for a model with self and simple mixed carryover effects , 2002 .

[12]  A. S. Hedayat,et al.  Optimal Two-Period Repeated Measurements Designs , 1990 .

[13]  John Stufken,et al.  Optimal and Efficient Crossover Designs Under Different Assumptions About the Carryover Effects , 2003, Journal of biopharmaceutical statistics.

[14]  Gregory C. Reinsel,et al.  Optimal two-period repeated measurement designs with two or more treatments , 1993 .

[15]  H. Kushner,et al.  Allocation rules for adaptive repeated measurements designs , 2003 .

[16]  Gregory C. Reinsel,et al.  Investigation of dual-balanced crossover designs for two treatments , 1992 .

[17]  E Laska,et al.  Optimal crossover designs in the presence of carryover effects. , 1983, Biometrics.

[18]  A. Willan,et al.  Using baseline measurements in the two-period crossover clinical trial. , 1986, Controlled clinical trials.

[19]  J. Grizzle THE TWO-PERIOD CHANGE-OVER DESIGN AN ITS USE IN CLINICAL TRIALS. , 1965, Biometrics.

[20]  M. Putt Power to detect clinically relevant carry‐over in a series of cross‐over studies , 2006, Statistics in medicine.

[21]  M. Hills,et al.  The two-period cross-over clinical trial. , 1979, British journal of clinical pharmacology.

[22]  A. Hedayat,et al.  Repeated Measurements Designs, II , 1978 .

[23]  Changbao Wu,et al.  Balanced Repeated Measurements Designs , 1980 .

[24]  M. Corbett Cross‐over designs for clinical trials , 1991, The British journal of dermatology.

[25]  J. Fleiss,et al.  Adjusting for baseline measurements in the two-period crossover study: a cautionary note. , 1985, Controlled clinical trials.

[26]  K C Carriere,et al.  Crossover designs for clinical trials. , 1994, Statistics in medicine.

[27]  Joachim Kunert,et al.  Optimal Design and Refinement of the Linera Model with Applications to Repeated Measurements Designs , 1983 .